Loading clinical trials...
Loading clinical trials...
A Phase II Study of the Efficacy, Safety, and Cost of Frameless Fractionated Stereotactic Radiation for Parenchymal Brain Metastases
Conditions
Interventions
Frameless Fractionated Stereotactic Radiation Therapy
Locations
4
United States
Presbyterian Hospital
Albuquerque, New Mexico, United States
MD Anderson in The Woodlands
Conroe, Texas, United States
M D Anderson Cancer Center
Houston, Texas, United States
MD Anderson West Houston
Houston, Texas, United States
Start Date
August 8, 2016
Primary Completion Date
April 19, 2024
Completion Date
April 19, 2024
Last Updated
April 23, 2024
NCT06500455
NCT04988009
NCT03270059
NCT05588453
NCT02754544
NCT03741673
Lead Sponsor
M.D. Anderson Cancer Center
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions